Abstract
BBS8 is one of the eight genes identified to date for Bardet–Biedl syndrome (BBS)—an autosomal recessive condition associated with retinitis pigmentosa, obesity, polydactyly, cognitive impairment and kidney failure. The identification of BBS8 gave the key to the pathogenesis of the condition as a primary ciliary disorder. To date, only three families mutated in the BBS8 gene have been reported. Here, we report on three additional families with BBS8 mutations from a series of 128 BBS families. Two of the three families have homozygous mutations and one has a heterozygous mutation. Mutations in BBS8 probably account for only a minority of BBS families (2%), underlining the difficulty of genotyping heterogeneous conditions.
Introduction
Bardet–Biedl syndrome (BBS) is a genetically heterogeneous condition characterised by early-onset retinitis pigmentosa, obesity, polydactyly, hypogonadism, learning disabilities, and kidney malformation. A tremendous amount of knowledge about BBS has recently accumulated, demonstrating extensive genetic heterogeneity and giving clues as to the ciliary pathogenesis of this complex condition. It has also been suggested that its inheritance may depart from the classic autosomal recessive mode, and may involve, in some families, three mutated alleles in two genes (triallelic inheritance) (Katsanis et al. 2001).
To date, eight BBS genes have been identified: BBS1 (11q13; Mykytyn et al. 2002), BBS2 (16q21; Nishimura et al. 2001); BBS3 (3p13-p12; Fan et al. 2004; Chiang et al. 2004), BBS4 (15q22.3-q23; Mykytyn et al. 2001); BBS5 (2q31; Li et al. 2004); BBS6 (20 p12; Slaovotinek et al. 2000; Katsanis et al. 2000), BBS7 (4q27; Badano et al. 2003) and BBS8 (14q32.11; Ansley et al. 2003).
The identification of BBS8, encoding a centrosomal and basal body protein, designated BBS as a primary cilia disorder (Ansley et al. 2003). Since then, functional overlap between BBS genes at the level of basal body and cilia is now well recognized and various bbs transgenic mice have been reported.
BBS8 maps to the 14q32.11 region and spans 15 exons. The BBS8 protein (TTC8), like BBS4, contains several tetratricopeptide repeats (TPRs) involved in protein–protein interactions. This protein is associated with centriolar structures and interacts with PCM-1, which is involved with basal body function (Ansley et al. 2003).
To date, mutations in BBS8 have been reported only for three families (Ansley et al. 2003): two families of Saudi Arabian lineage have a homozygous in-frame deletion of 6 bp in exon 6, and one family of Pakistani descent was reported to have a 3-bp deletion at the splice site junction of exon 10. Herein, we report BBS8 mutations in three BBS families out of a cohort of 128 BBS families.
Materials and methods
Families
This study was performed on a series of 128 families containing one or more patients with a diagnosis of BBS (Beales et al. 1999).
Methods
Mutation screening in BBS8 was performed by DHPLC analysis using at least three melting temperatures for each amplicon, followed by direct sequencing of the variant PCR fragments as described previously (Hichri et al. 2005). Splice site scoring programs (http://l25.itba.mi.cnr.it/~webgene/wwwspliceview.html, http://www.fruitfly.org/seq_tools/splice.html) were used to evaluate the effect of mutations affecting splice sites and to detect potential consequences on splicing of silent, or missense changes and intronic variations. ESE web servers (http://genes.mit.edu/burgelab/rescue-ese, http://rulia.cshl.edu/tools/ESE) were used to search for potential exonic splicing enhancers in exonic variants (silent or missense mutations).
Results
Three families with BBS8 mutations were identified, of which two showed homozygous mutations and one showed a heterozygous mutation.
Family one is a consanguineous family of North-African descent with three BBS affected sibs and three non-affected sibs (Fig. 1). Affected sibs harboured a homozygous splice-site mutation (T153T, 459G>A) affecting the last G of exon 4 of BBS8 and predicted to abolish the splice site of exon 4. Screening for other BBS genes for this family revealed an additional BBS7 mutation (M114 V, 340A>G) for one sib only (Figs. 1, 2). This mutation is predicted to affect the donor splice site of exon 4 of BBS7. No clinical difference was recorded for the three BBS sibs and no cell-line is available.
Family two is a sporadic case of Lebanese lineage. The proband, born from a consanguineous marriage, showed a homozygous splice site mutation (IVS6 + 1G>A) at the level of exon 6 of BBS8 (the DNA of other members of the family is not available) (Fig. 2). No other mutation in any known BBS gene has been identified to date.
Family three, a sporadic case born from caucasian non-consanguineous parents carried a heterozygous mutation in the donor splice site of exon 6 of BBS8 (IVS6+1−2delGT) (Fig. 2).
Two exonic variations were identified during this study. The R79R change, which creates a weak exonic splicing enhancer (ESE), found in one patient was not found in 137 matched controls. The K85R change found in three patients and in one control out of 137 matched controls is predicted to abolish two ESEs. Functional analysis was not feasible as no cell lines are available. Table 1 summarises the variations found in the BBS8 gene during this study.
Conclusions
Mutations in BBS8 remain rare events in BBS family cohorts. BBS8 mutations were found in only 1% (3/259) of the families studied in an earlier publication, and in 2% (3/128) of the families examined in this study. The Pakistani family in Ansley’s paper presented with a BBS phenotype associated with Situs Inversus; however, to our knowledge, none of the patients reported herein exhibited this feature. BBS7 and BBS8 have been found to participate in the same process at the level of ciliary intraflagellar transport (Blacque et al. 2004). Interestingly, only one patient in family one harboured a “third mutated allele”; however, the BBS7 heterozygous mutation predicted to affect splicing is not present in affected siblings, casting doubt on its pathogenicity as no clinical differences between the siblings were noted. To date, BBS1 is the major BBS gene, accounting for at least 20% of BBS gene mutations found in affected families (Hichri et al. 2005). About 50% of the BBS families in various studies do not carry mutations in known BBS genes, suggesting that other genes remain to be identified. Numerous genes are probably involved in this unique syndrome and traditional genotyping remains a difficult task, stressing the need for automated genotyping for heterogeneous conditions.
References
Ansley SJ, Badano JL, Blacque OE et al (2003) Basal body dysfunction is a likely cause of pleiotropic Bardet-Biedl syndrome. Nature 425:628–633
Badano JL, Ansley SJ, Leitch CC, Lewis RA, Lupski JR, Katsanis N (2003) Identification of a novel Bardet-Biedl Syndrome protein, BBS7, that shares structural features with BBS1 and BBS2. Am J Hum Genet 72:650–658
Beales PL, Elcioglu N, Woolf AS, Parker D, Flinter FA (1999) New criteria for improved diagnosis of Bardet-Biedl syndrome: results of a population survey. J Med Genet 36:437–446
Blacque OE, Reardon MJ, Li C, McCarthy J, Mahjoub MR, Ansley SJ, Badano JL, Mah AK, Beales PL, Davidson WS, Johnsen RC, Audeh M, Plasterk RH, Baillie DL, Katsanis N, Quarmby LM, Wicks SR, Leroux MR (2004) Loss of C. elegans BBS-7 and BBS-8 protein function results in cilia defects and compromised intraflagellar transport. Genes Dev 18:1630–1642
Chiang AP, Nishimura D, Searby C et al (2004) Comparative genomic analysis identifies an ADP-ribosylation factor-like gene as the cause of Bardet-Biedl syndrome (BBS3). Am J Hum Genet 75:475–484
Fan Y, Esmail MA, Ansley SJ et al (2004) Mutations in a member of the Ras superfamily of small GTP-binding proteins causes Bardet-Biedl syndrome. Nat Genet 36:989–993
Hichri H, Stoetzel C, Laurier V, Caron S, Sigaudy S, Sarda P, Hamel C, Martin-Coignard D, Gilles M, Leheup B, Holder M, Kaplan J, Bitoun P, Lacombe D, Verloes A, Bonneau D, Perrin-Schmitt F, Brandt C, Besancon AF, Mandel JL, Cossee M, Dollfus H (2005) Testing for triallelism: analysis of six BBS genes in a Bardet-Biedl syndrome family cohort. Eur J Hum Genet 13:607–616
Katsanis N, Beales PL, Woods MO et al (2000) Mutations in MKKS cause obesity, retinal dystrophy and renal malformations associated with Bardet-Biedl syndrome. Nat Genet 26:67–70
Katsanis N, Ansley SJ, Badano JL et al (2001) Triallelic inheritance in Bardet-Biedl syndrome, a Mendelian recessive disorder. Science 293:2256–2259
Li JB, Gerdes JM, Haycraft CJ et al (2004) Comparative genomics identifies a flagellar and basal body proteome that includes the BBS5 human disease gene. Cell 117:541–552
Mykytyn K, Braun T, Carmi R et al (2001) Identification of the gene that, when mutated, causes the human obesity syndrome BBS4. Nat Genet 28:188–191
Mykytyn K, Nishimura DY, Searby CC et al (2002) Identification of the gene (BBS1) most commonly involved in Bardet-Biedl syndrome, a complex human obesity syndrome. Nat Genet 31:435–438
Nishimura DY, Searby CC, Carmi R et al (2001) Positional cloning of a novel gene on chromosome 16q causing Bardet-Biedl syndrome. Hum Mol Genet 10:865–874
Slavotinek AM, Stone EM, Mykytyn K et al (2000) Mutations in MKKS cause Bardet-Biedl syndrome. Nat Genet 26:15–16
Acknowledgements
We wish to acknowledge the financial support of: Ministère de la Recherche (PHRC national 2002), RETINA France, LION’s club du Kochersberg and la Fédération des Maladies Orphelines, the constant technical help of the IGBMC (Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch-Graffenstaden), INSERM, CNRS and the Université Louis Pasteur de Strasbourg.
Author information
Authors and Affiliations
Corresponding author
Additional information
C. Stoetzel and V. Laurier contributed equally to this work
Rights and permissions
About this article
Cite this article
Stoetzel, C., Laurier, V., Faivre, L. et al. BBS8 is rarely mutated in a cohort of 128 Bardet–Biedl syndrome families. J Hum Genet 51, 81–84 (2006). https://doi.org/10.1007/s10038-005-0320-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10038-005-0320-2
Keywords
This article is cited by
-
A novel mutation in TTC8 is associated with progressive retinal atrophy in the golden retriever
Canine Genetics and Epidemiology (2014)
-
Identification of 28 novel mutations in the Bardet–Biedl syndrome genes: the burden of private mutations in an extensively heterogeneous disease
Human Genetics (2010)